Analysis of the 42,000 public comments submitted to the Drug Enforcement Administration (DEA) regarding cannabis rescheduling shows ‘overwhelming support’ for reform.
New analysis from cannabis data platform Headset shows an ‘unprecedented’ level of engagement from the American public, with the response to cannabis rescheduling breaking the previous engagement record of 38,000 comments, submitted in 2020 regarding controversial telemedicine rules, comfortably.
More importantly, the vast majority of responses submitted were in favour of the proposals to move cannabis from a Schedule I substance to Schedule III, with many suggesting that the DEA should go even further and deschedule cannabis altogether.
According to Headset’s analysis, 92.45% of comments were in favour of changing cannabis’s schedule in the Controlled Substances Act (CSA), meaning just 7.55% of respondents were against the change.
Furthermore, the majority of respondents (61.7%) called for cannabis to be descheduled completely, while 38.3% supported rescheduling to a less restrictive category.
“This overwhelming show of public support, equivalent to the unanimous voice of an entire state capital, sends a powerful message to policymakers. It suggests that not only is there broad backing for the proposed rescheduling, but there’s also a significant push for even more comprehensive reform,” the company stated.
A number of key themes were also revealed during Headset’s analysis. One ‘notable phenomenon’ was the appearance of distinct spikes in comments opposing rescheduling that coincided with coordinated efforts by opposition groups.
One significant instance occurred on July 15, when Smart Approaches to Marijuana (SAM), an organization against cannabis legalization, issued a call to action to its supporters. SAM provided a form letter and urged supporters to submit comments, resulting in a noticeable surge in opposition submissions on that day.
These findings underscore the impact of organized advocacy groups on public comment periods and highlight the importance of examining both the content and timing of comments to fully understand public sentiment.
Despite the overwhelming public support for the rescheduling, a number of significant challenges remain, including the potential waning of political support for the move should no progress be made before November’s presidential election.
Over 90% of Cannabis Rescheduling Comments Are in Favour of the Move, With the Majority Calling for Further Reform
Analysis of the 42,000 public comments submitted to the Drug Enforcement Administration (DEA) regarding cannabis rescheduling shows ‘overwhelming support’ for reform.
New analysis from cannabis data platform Headset shows an ‘unprecedented’ level of engagement from the American public, with the response to cannabis rescheduling breaking the previous engagement record of 38,000 comments, submitted in 2020 regarding controversial telemedicine rules, comfortably.
More importantly, the vast majority of responses submitted were in favour of the proposals to move cannabis from a Schedule I substance to Schedule III, with many suggesting that the DEA should go even further and deschedule cannabis altogether.
According to Headset’s analysis, 92.45% of comments were in favour of changing cannabis’s schedule in the Controlled Substances Act (CSA), meaning just 7.55% of respondents were against the change.
Furthermore, the majority of respondents (61.7%) called for cannabis to be descheduled completely, while 38.3% supported rescheduling to a less restrictive category.
“This overwhelming show of public support, equivalent to the unanimous voice of an entire state capital, sends a powerful message to policymakers. It suggests that not only is there broad backing for the proposed rescheduling, but there’s also a significant push for even more comprehensive reform,” the company stated.
A number of key themes were also revealed during Headset’s analysis. One ‘notable phenomenon’ was the appearance of distinct spikes in comments opposing rescheduling that coincided with coordinated efforts by opposition groups.
One significant instance occurred on July 15, when Smart Approaches to Marijuana (SAM), an organization against cannabis legalization, issued a call to action to its supporters. SAM provided a form letter and urged supporters to submit comments, resulting in a noticeable surge in opposition submissions on that day.
These findings underscore the impact of organized advocacy groups on public comment periods and highlight the importance of examining both the content and timing of comments to fully understand public sentiment.
Despite the overwhelming public support for the rescheduling, a number of significant challenges remain, including the potential waning of political support for the move should no progress be made before November’s presidential election.
Cannabis Rescheduling Enters Next Phase as Comment Period Closes
Next PostCanadian Cannabis Council Pushes Back on Israel’s Threats to Tax Imports
Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, they have researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Related Posts
Related Posts
US House Votes to Allow VA Doctors to Recommend Medical Cannabis in Landmark Veterans Health Bill
Doctors at the US Department of Veterans Affairs (VA) may soon be allowed to recommend medical cannabis to patients, following...
The New Federal Government Drugs Commissioner Remains Vague on the Cannabis Issue
With the appointment of Prof. Dr. Hendrik Streeck as the new Federal Government Commissioner for Drugs, Burkhard Blienert had to...
Delaware to Launch Recreational Cannabis Sales on 1 August
The Platform That Could Rewrite the Future of Cannabis Drug Discovery
‘Seminal Moment’: Texas Hemp-Killing Bill Blocked as State Doubles Down on Medical Cannabis
Congress Amends Language of Potential Hemp-Killing Bill, But Industry Warns Non-Intoxicating Hemp Still Under Existential Threat
CONNECT
Related Posts
Related Posts
US House Votes to Allow VA Doctors to Recommend Medical Cannabis in Landmark Veterans Health Bill
Doctors at the US Department of Veterans Affairs (VA) may soon be allowed to recommend medical cannabis to patients, following...
The New Federal Government Drugs Commissioner Remains Vague on the Cannabis Issue
With the appointment of Prof. Dr. Hendrik Streeck as the new Federal Government Commissioner for Drugs, Burkhard Blienert had to...
Delaware to Launch Recreational Cannabis Sales on 1 August
Delaware will become the 22nd US state to launch a regulated adult-use cannabis market when retail sales begin on 1...
The Platform That Could Rewrite the Future of Cannabis Drug Discovery
At its core, Standard Seed AI's technology has the power to scientifically validate the entourage effect, streamline drug discovery, and...
‘Seminal Moment’: Texas Hemp-Killing Bill Blocked as State Doubles Down on Medical Cannabis
Texas medical cannabis and hemp businesses both enjoyed some major, yet largely unexpected news over the weekend, not only ensuring...
Recent Posts
Related Posts
US Spending Bill Takes Aim at Cannabis Rescheduling Project
As more details of the Trump administration’s fiscal plans for the year ahead come to light, so do more thinly...
Cannabis Rescheduling Given Fresh Hope as DEA Nominee Pledges to ‘Look at Science and Listen to Experts’
Cannabis rescheduling was thrown back into the spotlight last week as the new potential head of the Drug Enforcement Administration...
Legal Challenge Over DEA’s Handling of Cannabis Rescheduling Dropped, Removing 1 Barrier Preventing Progress
A coalition of pro-cannabis medical professionals has dropped its lawsuit against the Drug Enforcement Administration (DEA), clearing one of the...
Cannabis Rescheduling ‘Delayed Not Dead’, Despite DEA’s Apathy
The US Cannabis Roundtable (USCR), one of the most influential advocacy groups in the country, is ‘still optimistic about the...
Cannabis Stocks Rally on Gaetz Assertion Cannabis Rescheduling ‘Finally on the Horizon’
Controversial former congressman and Trump loyalist Matt Gaetz sent cannabis stocks rallying last week after suggesting in an op-ed that...
Subscribe to our mailing list to receives daily updates!
We won’t spam you
Categories
Browse by Tags